Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Name: Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
License: Public Domain

Novartis Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetic macular edema

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 394704
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.